aminoglutethimide has been researched along with Cancer of Liver in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ceccherini, R; Dellach, C; Leita, ML; Milani, S; Muggia, M; Mustacchi, G | 1 |
Gale, KE | 1 |
Bettelheim, R; Chilvers, C; Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Gordon, C; Powles, TJ; Smith, IE; Zava, D | 1 |
Coombes, RC; Ford, HT; Gazet, JC; Harmer, C; Jones, M; McKinna, JA; Powles, TJ; Smith, IE | 1 |
Fahmy, DR; Fitzharris, BM; Ford, HT; Gazet, JC; McKinna, JA; Nash, AG; Neville, AM; Powles, TJ; Smith, IE | 1 |
Adshead, F; De Graeff, A; Mansi, JL; Smith, IE; Thomas, DM | 1 |
Cantwell, BM; Dawes, PJ; Evans, RG; Farndon, J; Harris, AL; Needham, G; Sainsbury, JR; Wilson, R | 1 |
2 trial(s) available for aminoglutethimide and Cancer of Liver
Article | Year |
---|---|
A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Breast Neoplasms; Cisplatin; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Megestrol Acetate; Middle Aged; Neoplasm Staging; Probability; Risk Assessment; Soft Tissue Neoplasms; Survival Analysis; Tamoxifen; Vinblastine; Vinorelbine | 2002 |
Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress report.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Drug Administration Schedule; Estrone; Female; Humans; Hydrocortisone; Liver Neoplasms; Menopause; Middle Aged; Neoplasm Staging; Radiography; Random Allocation; Receptors, Estrogen | 1982 |
5 other study(ies) available for aminoglutethimide and Cancer of Liver
Article | Year |
---|---|
Treatment of advanced breast cancer with aminoglutethimide: a 14-year experience.
Topics: Adrenalectomy; Aminoglutethimide; Breast Neoplasms; Dexamethasone; Drug Evaluation; Female; Hormones; Humans; Liver Neoplasms; Palliative Care; Risk | 1982 |
Aminoglutethimide in the management of advanced breast cancer.
Topics: Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms | 1980 |
Aminoglutethimide in treatment of metastatic breast carcinoma.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Soft Tissue Neoplasms | 1978 |
Small cell carcinoma of the prostate: implications for management.
Topics: Adenocarcinoma; Aminoglutethimide; Bone Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Humans; Liver Neoplasms; Male; Middle Aged; Prostatic Neoplasms | 1991 |
Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Hydrocortisone; Liver Neoplasms; Lung Neoplasms; Menopause; Prognosis | 1986 |